Genentech, a member of the Roche Group (OTC: RHHBY), announced data from the positive, pivotal Phase III OAK study of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE